Delivery Order SPE2DB22D1200-SPE2DB23FN3EU
Award Date 7/10/23
Potential Completion Date 7/11/23
Potential Value $364
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,655.53 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 boxes of 8 mg ramelteon tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 2, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award information....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,122 to Amerisourcebergen Drug Corporation. The order is for 30 packages of 8mg Ramelteon tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 7, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform as the prime contractor under this order placed against an existing DLA contract vehicle. No set aside designation or...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifteen thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of thirty boxes of eight milligram ramelteon tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from September 6 to September 7, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of...
- The Defense Logistics Agency awarded a $596.88 delivery order to Amerisourcebergen Drug Corporation for the provision of 30 Ramelteon 8 mg tablets. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will fulfill the order from its place of performance in Conshohocken, Pennsylvania under a firm fixed price arrangement. The order is funded by the Defense Logistics Agency and has a period of performance spanning August 21, 2023 through August 22, 2023. No set...
- The Defense Logistics Agency awarded a $248,280 delivery order to Amerisourcebergen Drug Corporation for 30 boxes containing 8 mg tablets of ramelteon. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical products to be shipped to a facility in Conshohocken, Pennsylvania by July 31, 2023. As a leading distributor of drugs to the U.S. military, Amerisourcebergen will fulfill this order from the Defense Logistics Agency to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $140 firm fixed price delivery order contract from the Defense Logistics Agency to supply 30 boxes of 8mg ramelteon tablets. Performance will take place in Conshohocken, Pennsylvania, with all products to be delivered by October 2, 2023. No set-aside provisions were applied to this order, which was issued under an existing DLA vehicle to fulfill pharmaceutical needs for various military treatment...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,431.92 for Ramelteon 8 mg tablets (30-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency awarded a $29,160 delivery order to Amerisourcebergen Drug Corporation for 30 boxes of 8 mg Ramelteon tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 21-24, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to ensure medical supplies and pharmaceuticals are...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,465.53 to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets in unit dose packaging (50-count) with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price contract utilized no set-aside designation and represents a direct delivery order fulfillment for pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,511.45 contract is for the provision of 30-count tablets of the pharmaceutical drug Ramelteon 8 mg. The delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that has received numerous federal contract awards from DLA...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB23FN3EUDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $364.25 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 100 boxes of 8mg Ramelteon tablets to support the Department of Defense's medical supply needs. As the prime contractor, Amerisourcebergen will leverage its corporate infrastructure and distribution network based in Conshohocken, Pennsylvania to fulfill delivery of the pharmaceutical products to the customer by July 11, 2023. No subcontractors or set aside designations were identified in the award provided. The contract award is consistent with DLA's mission to provide medical supplies to the DoD worldwide.
Generated 12/22/23, 12:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $364 | 7/10/23 |